346357
4′-(Trifluoromethyl)-2-biphenylcarboxylic acid
97%
Sign Into View Organizational & Contract Pricing
All Photos(1)
CF3C6H4C6H4CO2H
Recommended Products
Assay
97%
form
solid
mp
169-171 °C (lit.)
SMILES string
OC(=O)c1ccccc1-c2ccc(cc2)C(F)(F)F
InChI
1S/C14H9F3O2/c15-14(16,17)10-7-5-9(6-8-10)11-3-1-2-4-12(11)13(18)19/h1-8H,(H,18,19)
InChI key
IQOMYCGTGFGDFN-UHFFFAOYSA-N
General description
4′-(Trifluoromethyl)-2-biphenylcarboxylic acid (xenalipin) has been tested as an effective hypolipidemic agent in animal species. It has been shown to cause significant reduction in serum cholesterol and triglyceride levels in animal models and would be beneficial in therapy for hyperlipidemia. Synthesis of 4′-(trifluoromethyl)-2-biphenylcarboxylic acid (xenalipin) has been reported. Xenalipin has been synthesized in the [14C]-labelled form, with specific activity 21.0mCi/mmol, which is suitable for the metabolism and distribution studies in animals.
Application
4′-(Trifluoromethyl)-2-biphenylcarboxylic acid may be used in chemical synthesis.
WGK
WGK 3
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Personal Protective Equipment
dust mask type N95 (US), Eyeshields, Gloves
Regulatory Information
新产品
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
The Nickel (I) Catalyzed Coupling of a Diarylzinc with an Aryl Chloride in the Synthesis of Xenalipin.
Organic preparations and procedures international, 27(3), 367-372 (1995)
Synthesis of carbon-14 labelled xenalipin-a potential hypolipidemic agent.
Journal of Labelled Compounds & Radiopharmaceuticals, 31(12), 1011-1017 (1992)
Atherosclerosis, 64(1), 27-35 (1987-03-01)
Xenalipin (4'-trifluoromethyl-2-biphenylcarboxylic acid) is a chemically novel compound which has been found to be an effective hypolipidemic agent in two animal species. Significant reductions in serum cholesterol and triglycerides were observed in cholesterol-cholic acid-fed rats following oral doses of 10-30
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service